Safe Orthopaedics SA (FRA:OR9)

Germany · Delayed Price · Currency is EUR

0.4500

-0.0600 (-11.76%)

At close: Jun 26, 2026

-79.55% (1Y)

Market Cap	56.10K -74.4%
Revenue (ttm)	5.04M -2.9%
Net Income	-1.93B
EPS	-0.93
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.4500
Previous Close	0.5100
Day's Range	0.4500 - 0.4500
52-Week Range	0.4000 - 2.8000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 10, 2026

About Safe Orthopaedics

Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. The company was foun... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2010

Employees 77

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol OR9

Financial Performance

In 2024, Safe Orthopaedics's revenue was 5.04 million, a decrease of -13.24% compared to the previous year's 5.81 million. Losses were -1.93 billion, 839.1% more than in 2023.

Financial Statements